It was finally in 2013 that a landmark study by Maxson et al. discovered the colony-stimulating factor 3 receptor (CSF3R) oncogene as a key mutation in patients with CNL [6]. The gene discussed is CSF3R; the disease is chronic neutrophilic leukemia.